Heading Title
-
Insecticide Resistance Action Committee (IRAC)Resistance Action Committee (RAC)
Insecticide Resistance Action Committee (IRAC) – Published New Mode of Action Classification – including Nematicides Mode of Action Classification – March 2023
The Insecticide Resistance Action Committee published – Mode of Action (MOA) Classification Brochure 10.5 Edition, Now including Nematicides IRAC Mode of Action (MOA) Classification Scheme, Version 10.5. IRAC Poster Edition …
-
Corteva Agriscience announced the commercial launch of Adavelt™ active, with recent product registrations in three countries – Australia, Canada and South Korea. Adavelt active is a novel fungicide with a …
-
AgrochemicalsCorteva
Corteva Agriscience Announces Commercial Launch of Vorceed™ Enlist®(Glyphosate, Glufosinate, 2,4-D choline and FOP)for Corn productsL
Corteva Agriscience today announced plans for the commercial launch of Vorceed™ Enlist® corn products. U.S. farmers will access Vorceed Enlist corn technology across Pioneer® seeds, Dairyland Seed® and Brevant® seeds …
-
Adama
ADAMA Canada to Offer new Herbicide DAVAI A Plus (Imazamox +Clethodim)for Imi-tolerant lentils, as well as Peas and Soybeans
Summary:- DAVAI A PLUS™ combines 2 actives Imazamox ,Clethodim to tackle broadleaf and grassy weeds. DAVAI A Plus, a new pulse crop protection product available for 2023 crop year ADAMA …
-
ImazethapyrIndia
India Receives the First non-GM , Herbicide-Tolerant Rice Cultivars by The Indian Agricultural Research Institute (IARI)
Summary :- The varieties — Pusa Basmati 1979 and Pusa Basmati 1985 — contain a mutated acetolactate synthase (ALS) gene making it possible for farmers to spray Imazethapyr, a broad-spectrum …
-
AgrochemicalsIFFCO and Mitsubishi Corporation
IFFCO and Mitsubishi Corporation Developed Sasage (Sulphur 80% WDG)Fungicide
Summary-:IFFCO and Mitsubishi Corporation collaboratively developed Sasage, a contact fungicide to help farmers combat fungal diseases. Fungicides are substances that either eliminate or stop the development of fungi and their …
-
Intellectual Property (IP)Patent LitigationPatents
TRIAZOLINONE HERBICIDE SULFENTRAZONE WITH DIURON HERBICIDE MIXTURE FORMULATION INDIAN PATENT GRANTED TO FMC QUÍMICA DO BRASIL LTDA
FMC QUÍMICA DO BRASIL LTDA filed International PCT Patent Application (WO2016015113 A1) covering Triazolinone Herbicide Sulfentrazone Herbicide Diuron Mixture (synergistic herbicidal formulation), Indian family equivalent granted in India, e.g. IN419813 …
-
Insecticide Resistance Action Committee (IRAC)Resistance Action Committee (RAC)
Insecticide Resistance Action Committee (IRAC) – Published New Mode of Action Classification – including Nematicides Mode of Action Classification – 2023
The Insecticide Resistance Action Committee published – Mode of Action (MOA) Classification Brochure 7th Edition, Version 7.2. IRAC Mode of Action (MOA) Classification Scheme, Version 10.3. IRAC Poster Edition 10.4, …
-
Fungicide Resistance Action Committee (FRAC)Resistance Action Committee (RAC)
FRAC Mode of Action Poster – Published Version 2022
The organization known as the Fungicide Resistance Action Committee (FRAC) was established by industry and research scientists to be an overseeing group to monitor fungicide resistance and provide guidelines for …
-
444 RC MeetingCIBRC - Indian Pesticide ApprovalsRC Meeting updatesRegulatory
INDIAN PESTICIDE APPROVAL UPDATES – MINUTES OF THE 444th REGISTRATION COMMITTEE (RC) MEETING HELD ON 16.01.2023
The 444th meeting of the Registration Committee (RC) was held under the Chairmanship of Dr. K. Singh, Chairman, Registration Committee on 16.01.2023 at 10:30 hrs onwards in PPA Secretariat, DPPQ&S, …
-
443RC meetingActive Agrochemical IngredientChlorantraniliproleCIBRC - Indian Pesticide ApprovalsRC Meeting updatesRegulatory
INDIAN PESTICIDE APPROVALS – 443RD RC MEETING – CHLORANTRANILIPROLE – APPROVALS – MAJOR HIGHLIGHT
INDIAN PESTICIDE APPROVALS – 443RD RC MEETING – CHLORANTRANILIPROLE – APPROVALS – MAJOR HIGHLIGHT MINUTES OF THE 443rd REGISTRATION COMMITTEE MEETING HELD ON 22.12.2022. The 443rd meeting of the Registration …
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Icafolin-Methyl
NEW ISO CANDIDATE – ICAFOLIN-METHYL (ISO 1750) – BY BAYER CROP SCIENCE IN HERBICIDE CLASS
MOLECULE DETAILS: STATUS: Modified ISO 1750 (provisionally approved) IUPAC NAME: methyl (2RS,4RS)-4-({[(5S)-3-(3,5-difluorophenyl)-5-vinyl-4,5-dihydroisoxazol-5-yl]carbonyl}amino)tetrahydrofuran-2-carboxylate containing 40–70% of the (2R,4R)-isomer and 60–30% of the (2S,4S)-isomer CAS REG. NO.: 2749998-21-6 FORMULA: C18H18F2N2O5 ACTIVITY: Herbicides …
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Icafolin
BAYER CROP SCIENCE HERBICIDE CANDIDATE – ICAFOLIN – GOT ISO STATUS-1750
Icafolin is a herbicide, which is highly effective against economically important harmful plants even at relatively low application rates and can be used selectively in crop plants, preferably with good …
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Pyraquinate
NEW ISO HERBICIDE CANDIDATE 2023 – PYRAQUINATE – BY SHANDONG CYNDA CHEMICAL CO., LTD., CHINA IN HERBICIDE CLASS
Pyraquinate is a herbicide containing the quinazolinone compound and provides a novel HPPD-based inhibitor which has excellent control effects on weeds in crop fields such as paddy fields and high …
-
Summary:- BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a one-hour infusion twice-a-year following the …
-
RegulatoryU.S FDA
FDA Approves Adstiladrin , First Gene Therapy for the Treatment of High-risk, Non-muscle-invasive bladder cancer to Ferring Pharmaceuticals
Summary:- Ferring’s novel adenovirus vector-based gene therapy Adstiladrin® (nadofaragene firadenovec-vncg) is the first gene therapy approved for bladder cancer Efficacy and safety of Adstiladrin supported by Phase 3 results demonstrating that more than …
-
GileadRegulatoryU.S FDA
Sunlenca® (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for People Living With Multi-Drug Resistant HIV
Summary :- Sunlenca is the First and Only Approved Capsid Inhibitor-Based HIV Treatment Option New Drug Application Approval Based on High Rates of Sustained Virologic Suppression in the CAPELLA Trial …
-
GskPharma Science & Research
GSK and Wave Life Sciences Establish a Partnership to further the Identification and Development of Therapeutic Oligonucleotides that Target Novel Genomic Targets.
GSK plc (LSE/NYSE: GSK) and Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced a strategic …
-
Mirati TherapeuticsRegulatoryU.S FDA
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Summary :-Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRAZATI™ (adagrasib), a targeted treatment …
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Indolauxipyr
NEW ISO – DEC 2022 || HERBICIDE CORTEVA CANDIDATE PUBLISHED – INDOLAUXIPYR
NEW ISO – DEC 2022 – HERBICIDE CORTEVA CANDIDATE PUBLISHED – INDOLAUXIPYR Corteva also known as Dow Agrosciences LLC LLC published a new ISO herbicide candidate – Indolauxipyr, company has …
-
IndiaLaunch
Indian Farmers Fertiliser Cooperative Limited and Mitsubishi Corporation Launches Takibi (Flubendiamide 20% WG) Insecticide
Highlights : IFFCO and Mitsubishi Corporation formed a joint venture to produce Tabiki (Flubendiamide 20% WG). The major causes of biotic stress on crops are insects or pests. Hence, to …
-
AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts) that offer …
-
442 RC meetingCIBRC - Indian Pesticide ApprovalsIndiaRC Meeting updates
INDIAN PESTICIDE APPROVALS – 442ND RC MEETING – CHLORANTRANILIPROLE – FMC MOLECULE – MAJOR HIGHLIGHT
INDIAN PESTICIDE APPROVALS UPDATES – MINUTES OF THE 442ND REGISTRATION COMMITTEE (RC) MEETING HELD ON 18.11.2022 The 442nd meeting of the Registration Committee (RC) was held under the Chairmanship of …
-
RegulatoryU.S FDA
FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection
Summary- The FDA has approved fecal microbiota, live-jslm (Rebyota; Ferring Pharmaceuticals) for the prevention of recurring Clostridioides difficile infection (CDI) among patients 18 years of age and older after an antibiotic …
-
ChemRobotics and AgbioInvestor are happy to announce the establishment of a new international partnership utilising the pharmacological intelligence platform of ChemRobotics. AgbioInvestor will distribute and sell ChemRobotics’ global pharmaceutical platform, …
-
RegulatoryU.S FDA
The FDA has Approved TZIELDTM (Teplizumab-mzwv) as the First and Only Medication Intended to Postpone the onset of Stage 3 Type 1 Diabetes (T1D) in Adult and Paediatric Patients with Stage 2 T1D Who are 8 Years of Age and Older.
Summary:- TZIELD is the first disease-modifying therapy in T1D, a life-threatening autoimmune disease In a clinical trial, in Stage 2 T1D patients, TZIELD delayed the median onset of Stage 3 …
-
RegulatoryU.S FDA
Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)
Summary: Approval based on superior survival outcomes of Libtayo plus chemotherapy, compared to chemotherapy alone, in a patient population with a wide range of disease characteristics Second advanced NSCLC indication …
-
CompaniesPfizerRegulatoryU.S FDA
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for relapsed or Refractory Multiple Myeloma
Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of people with relapsed or refractory …
-
RegulatoryU.S FDA
U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Summary-The Food and Drug Administration granted accelerated approval to teclistamab-cqyv (Tecvayli, Janssen Biotech, Inc.), the first bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager, for adult patients with relapsed or …
-
GskMerger / Acquisition
To Speed up R&D, GSK Announces an Expanded Partnership with Tempus in Precision Medicine.
GSK plc (LSE/NYSE: GSK) and Tempus, a US-based precision medicine company, have entered into a three-year collaboration agreement that provides GSK with access to Tempus’ AI-enabled platform, including its library …
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Broclozone
2022 Updates – Two New ISO Pesticides Published – Broclozone – Isoxazolidinone Herbicide — Isoxazolidinone Herbicides || Ledprona – RNA Biopesticide — GreenLight Biosciences
2022 Updates – Two new ISO Pesticides Published – Broclozone – Isoxazolidinone Herbicide || Ledprona – RNA biopesticide – GreenLight Biosciences Broclozone — (Isoxazolidinone Herbicides) Broclozone is a new herbicide …
-
RegulatoryU.S FDA
Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain
Next Generation Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to Optimize and Maintain Pain Relief Using Each Patient’s Response. Nevro Corp. (NYSE: NVRO), a …
-
ChlorantraniliproleIndia
Natco Pharma Launches Chlorantraniliprole Insecticide Natvol & Natligo in Indian Market.
Natco Pharma has launched two Chlorantraniliprole (CTPR) pesticide formulated combination products under the brand names: NATVOL: Chlorantraniliprole 8.8% + Thiamethoxam 17.5% SC; andb. NATLIGO: Chlorantraniliprole 9.3% + Lambda-cyhalothrin 4.6% ZC …
-
Agro Science & ResearchThe Nobel Prize
Swedish Geneticist Who Unmasked Lives of Ancient Humans Wins Medicine Nobel
Nobel Prize 2022: Svante Pääbo was given the award “for his discoveries concerning the genomes of extinct hominins and human evolution,” the Nobel Prize committee said. Considered the most prestigious …
-
Pharma Science & Research
National CDC-Funded Study Confirms that mRNA Vaccines Protect Against Serious COVID-19 During Pregnancy
The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against …
-
RegulatoryU.S FDA
Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) today announced that the U.S. Food and Drug Administration (FDA) has approved OMLONTI® (omidenepag isopropyl ophthalmic solution) …
-
Summary- Corteva, Inc. and Symborg announced that Corteva has signed a definitive agreement to acquire Symborg, a microbiological technology expert based in Murcia, Spain. Respected throughout the biologics industry, Symborg …
-
Active Agrochemical IngredientAgro Science & ResearchPemigatinibTGA
The Therapeutic Goods Administration (TGA) Approved PEMAZYRE (Pemigatinib)
Summary: Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The Therapeutic Goods Administration (TGA) has granted PEMAZYRE (pemigatinib) …
-
Active Agrochemical IngredientChlorantraniliprolePatent Litigation
Chlorantraniliprole Patent Litigation Outcome – Best Agrolife Ltd. & Natco to become First Indian Companies to launch Indigenously Manufactured Chlorantraniliprole (CTPR)
Best Agrolife Ltd. & Natco to become the First Indian Company to launch Indigenously Manufactured Best Agrolife Ltd Chlorantraniliprole CTPR technology is compounded into broad-spectrum insecticides that are used to …
-
Summary: The World Health Organization (WHO) has awarded prequalification to Mosquirix, GSK’s malaria vaccine. This is the first prequalification for a malaria vaccine GSK plc (LSE/NYSE: GSK) announced that the World …
-
RegulatoryU.S FDA
bluebird bio Receives FDA Accelerated Approval for SKYSONA®(elivaldogene autotemcel)Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD)
Synopsis: SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys with this devastating and fatal neurodegenerative disease. Elivaldogene autotemcel is made specifically …
-
RegulatoryU.S FDA
Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (Terlipressin) for Injection for the Treatment of Hepatorenal Syndrome (HRS)
Highlights: Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney function. Terlivaz is expected to be available in the U.S. in the …
-
Synopsis: On September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1 billion. With the purchase of Forma, Novo Nordisk now …
-
RegulatoryU.S FDA
Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection
Summary: First novel Long-Acting GCSF (LA-GCSF) product approved in over 20 years ROLVEDON™ developed using proprietary LAPSCOVERY™ technology with a differentiated molecular structure and proven safety and efficacy profile Commercial team ready …
-
Bristol Myers SquibbRegulatoryU.S FDA
Bristol Myers Squibb Notches another FDA Approval for Sotyktu™ (Deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis
Highlights: Bristol Myers Squibb’s Sotyktu, a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, is the only approved TYK2 inhibitor worldwide and the first innovation in oral treatment for moderate-to-severe plaque …
-
RegulatoryU.S FDA
QOL Medical, LLC receives FDA approval of Sucraid® (Sacrosidase) Oral Solution single-use containers for Patients with Congenital Sucrase-Isomaltase Deficiency (CSID)
QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, announced today that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid® single-use containers for patients more than 33 lb (15 kg) …
-
RegulatoryU.S FDAVertex
Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to 24 months
Summary: Orkambi was first approved in 2015 in the US and is now available in more than 30 countries. Vertex Pharmaceuticals Incorporated announced the US Food and Drug Administration (FDA) …
-
Boehringer IngelheimRegulatoryU.S FDA
Boehringer’s Spevigo (spesolimab) Bags First FDA Approval for Rare Skin Disease, for Generalized Pustular Psoriasis (GPP)
Synopsis: German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in the US. The FDA …
-
RegulatorySanofi Inc.U.S FDA
XenpozymeTM (Olipudase alfa-rpcp) Approved by FDA as First Disease-Specific Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease to Sanofi
Summary: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations) Xenpozyme is the first approved medication to treat symptoms that are not related to the central nervous system in patients with …
-
Highlights: ICAR-Indian Institute of Spices Research, Kozhikode, has signed an agreement with Bayer Crop Science Limited, Thane for capacity building, development of plant protection schedule and nematode management programmes. The …